[ad_1]
This is foreseen in the vaccination plan announced on Friday.
According to the ministry, after the vaccination of hospital doctors working with COVID-19 patients in Lithuania began in late December, their vaccination, both the first and second doses, is currently being completed.
At the same time, vaccination of high-risk patients, volunteers involved in COVID-19 treatment, nursing and supportive care staff, social care workers and caregivers in January is scheduled to be completed in both doses in February.
In January and February, the first dose of the vaccine is intended to be administered to coronavirus laboratory personnel, outbreak epidemiologists, polyclinics and other personal care professionals who do not have direct contact with COVID-19 patients, pharmacists, soldiers involved. in military or international operations., scouts, future Olympic and Paralympic athletes, members of your team, cancer patients, educators.
Vaccination of these people must be completed during the fight.
Also, in February, March and April, the goal will be to vaccinate both people over 80 people with both doses. Residents ages 65 to 79 would be vaccinated in April and May.
Vaccination of chronic patients would begin in May and continue until July.
In July and August, it is planned to vaccinate patients in specialized hospital psychiatric services who are subject to compulsory medical treatment by the court, as well as people who perform important functions for society.
Mass vaccination of the population is also scheduled to begin in July.
The Ministry emphasizes that this calendar is indicative, based on current information “on the scope of priority groups and vaccine supply plans.”
SAM states that it is based solely on the delivery schedules of two manufacturers, BionTech and Pfizer and Moderna.
“The quantities delivered in the second to the fourth quarter have been distributed, assuming that the supply of the vaccine will be even each week,” reports the ministry.
According to her, the calendar will be updated as new data becomes available.
Vaccination of survivors is scheduled three months after diagnosis of the disease.
The BionTech and Pfizer vaccines were launched in the community last month and the Moderna vaccine was approved in early January.
The European Union plans to approve the AstraZeneca vaccine later this week. The first shipments to Lithuania are expected in early February.
The AstraZeneca vaccine, developed in collaboration with the University of Oxford, is already being distributed in the UK.
[ad_2]
